Skip to main content
Top
Published in: Supportive Care in Cancer 9/2009

01-09-2009 | Original Article

Symptom clusters in patients with advanced cancers

Authors: Winson Y. Cheung, Lisa W. Le, Camilla Zimmermann

Published in: Supportive Care in Cancer | Issue 9/2009

Login to get access

Abstract

Goals of work

It has been observed that certain cancer symptoms frequently occur together. Prior research on symptom patterns has focused mainly on inpatients, early stage cancers, or a single cancer type or metastatic site. Our aim was to explore symptom clusters among outpatients with different advanced cancers.

Materials and methods

Symptom scores by the Edmonton Symptom Assessment Scale (ESAS) were routinely collected for patients attending the Oncology Palliative Care Clinics at Princess Margaret Hospital from January 2005 to October 2007. Principal component analysis (PCA) was performed for the entire patient cohort and within specific disease sites to determine inter-relationships of the nine ESAS symptoms.

Main results

A total of 1,366 patients was included: 682 (50%) were male and 684 (50%) were female. The median age was 64 years (range 18 to 74 years). The most common primary cancer sites were gastrointestinal (27%), lung (14%), and breast (11%). The three most distressful symptoms were fatigue, poor general well-being, and decreased appetite. PCA of symptoms for the entire patient cohort revealed two major symptom clusters: cluster 1 included fatigue, drowsiness, nausea, decreased appetite, and dyspnea, which accounted for 45% of the total variance; cluster 2 included anxiety and depression, which accounted for 10% of the total variance. There was high internal reliability in the clusters (Cronbach’s alpha coefficient ∼0.80). PCA of symptoms within the various primary cancer sites revealed differences in the pattern of symptom clusters.

Conclusions

In patients with advanced cancers, distinct symptom clusters can be identified, which are influenced by primary cancer site. Treatments directed at symptom clusters rather than individual symptoms may provide greater therapeutic benefit. Further prospective studies are warranted in order to develop more effective targeted palliative interventions for the advanced cancer patient population.
Literature
1.
go back to reference Argiles JM, Busquets S, Garcia-Martinez C, Lopez-Soriano FJ (2005) Mediators involved in the cancer anorexia–cachexia syndrome: past, present, and future. Nutrition 21:977–985PubMed Argiles JM, Busquets S, Garcia-Martinez C, Lopez-Soriano FJ (2005) Mediators involved in the cancer anorexia–cachexia syndrome: past, present, and future. Nutrition 21:977–985PubMed
4.
go back to reference Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton symptom assessment system (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7:6–9PubMed Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton symptom assessment system (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7:6–9PubMed
9.
go back to reference Cheung WY, Barmala N, Zarinehbaf S, Rodin G, Le LW, Zimmermann C (2008) The association of physical and psychological symptom burden with time to death among palliative cancer outpatients. J Pain Symptom Manage. doi:10.1016/j.jpainsymman.2008.03.008 Cheung WY, Barmala N, Zarinehbaf S, Rodin G, Le LW, Zimmermann C (2008) The association of physical and psychological symptom burden with time to death among palliative cancer outpatients. J Pain Symptom Manage. doi:10.​1016/​j.​jpainsymman.​2008.​03.​008
14.
go back to reference Dodd MJ, Miaskowski C, Paul SM (2001) Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum 28:465–470PubMed Dodd MJ, Miaskowski C, Paul SM (2001) Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum 28:465–470PubMed
16.
26.
go back to reference Kim HJ, McGuire DB, Tulman L, Barsevick AM (2005) Symptom clusters: concept analysis and clinical implications for cancer nursing. Cancer Nurs 28:270–284PubMed Kim HJ, McGuire DB, Tulman L, Barsevick AM (2005) Symptom clusters: concept analysis and clinical implications for cancer nursing. Cancer Nurs 28:270–284PubMed
34.
36.
37.
go back to reference Stromgren AS, Goldschmidt D, Groenvold M et al (2002) Self-assessment in cancer patients referred to palliative care: a study of feasibility and symptom epidemiology. Cancer 94:512–520 doi:10.1002/cncr.10222 PubMedCrossRef Stromgren AS, Goldschmidt D, Groenvold M et al (2002) Self-assessment in cancer patients referred to palliative care: a study of feasibility and symptom epidemiology. Cancer 94:512–520 doi:10.​1002/​cncr.​10222 PubMedCrossRef
41.
go back to reference Wang XS, Wang Y, Guo H, Mendoza TR, Hao XS, Cleeland CS (2004) Chinese version of the MD Anderson symptom inventory: validation and application of symptom measurement in cancer patients. Cancer 101:1890–1901 doi:10.1002/cncr.20448 PubMedCrossRef Wang XS, Wang Y, Guo H, Mendoza TR, Hao XS, Cleeland CS (2004) Chinese version of the MD Anderson symptom inventory: validation and application of symptom measurement in cancer patients. Cancer 101:1890–1901 doi:10.​1002/​cncr.​20448 PubMedCrossRef
42.
go back to reference Zimmermann C, Seccareccia D, Clarke A, Warr D, Rodin G (2006) Bringing palliative care to a Canadian cancer center: the palliative care program at Princess Margaret Hospital. Support Care Cancer 14:982–987 doi:10.1007/s00520-006-0093-y PubMedCrossRef Zimmermann C, Seccareccia D, Clarke A, Warr D, Rodin G (2006) Bringing palliative care to a Canadian cancer center: the palliative care program at Princess Margaret Hospital. Support Care Cancer 14:982–987 doi:10.​1007/​s00520-006-0093-y PubMedCrossRef
Metadata
Title
Symptom clusters in patients with advanced cancers
Authors
Winson Y. Cheung
Lisa W. Le
Camilla Zimmermann
Publication date
01-09-2009
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 9/2009
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-009-0577-7

Other articles of this Issue 9/2009

Supportive Care in Cancer 9/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine